Cargando…
Relations between approved platinum drugs and non-coding RNAs in mesothelioma
Malignant mesothelioma diseases feature an increasing risk due to their severe forms and their association with asbestos exposure. Platinum(II) complexes such as cisplatin and carboplatin are clinically approved for the therapy of mesothelioma often in combination with antimetabolites such as pemetr...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
KeAi Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260483/ https://www.ncbi.nlm.nih.gov/pubmed/30809599 http://dx.doi.org/10.1016/j.ncrna.2018.08.001 |